|
US2021018498A1
|
|
Reversible cell labelling with conjugates having two releasable binding sites
|
|
WO2021013669A1
|
|
Assay for identifing colony-forming cells
|
|
WO2021047804A1
|
|
In vitro method for transduction of t cells in the presence of malignant cells
|
|
WO2020239866A1
|
|
Method for generation of genetically modified t cells
|
|
WO2020207963A1
|
|
Conjugates having an enzymatically releasable detection moiety and a barcode moiety
|
|
US2020324031A1
|
|
Perestaltic pump and device for isolating cells from biological tissue
|
|
US2020299404A1
|
|
Method for providing personalized cells with chimeric antigen receptors (CAR)
|
|
US2020298241A1
|
|
Slide chamber
|
|
WO2020152197A1
|
|
A combination of compositions for elimination and enhanced engraftment of hematopoietic stem cells in the bone marrow of a subject
|
|
EP3792346A1
|
|
Method for the generation of a cell composition of ventral midbrain dopaminergic progenitor cells
|
|
WO2020025468A1
|
|
Non-specific nucleases from the genus pseudomonas
|
|
WO2020216439A1
|
|
Reversible cell detection with conjugates having a linker for increased fluorescent brightness and an enzymatically releasable fluorescent moiety
|
|
KR20200113211A
|
|
Regulatory T cells expressing chimeric antigen receptor
|
|
US2020353003A1
|
|
Chimeric Antigen Receptor Specific for BDCA2 Antigen
|
|
CN111566221A
|
|
Methods for NK cell transduction
|
|
CA3080424A1
|
|
Adapter-based retroviral vector system for the selective transduction of target cells
|
|
EP3655774A1
|
|
A method for single cell protein expression profiling of floorplate mesencephalic dopaminergic progenitor cells
|
|
EP3574305A1
|
|
Printed flow cell for photometer
|
|
EP3400983A1
|
|
Refillable column system
|
|
EP3336546A1
|
|
Reversible cell labelling with conjugates having two releasable binding sites
|
